Kerensa Jimenez serves as chief executive officer at Paragon Health Capital, providing advisory services to Paragon Biosciences portfolio companies for all stages of financing and M&A needs. She works closely with Paragon and the executive management teams of its portfolio companies to raise growth capital, ranging from Series A to pre-IPO rounds of financing (both equity and debt).

Kerensa Jimenez brings more than 20 years of experience advising clients on M&A and financing transactions. Prior to joining Paragon Health Capital, she served as managing director of Octagon Capital Group, a top-tier merchant bank that has led numerous transactions for Paragon Biosciences portfolio companies over the past several years. Earlier in her career, Ms. Jimenez was a director at Farlie Turner, a middle market investment bank, where she provided M&A advisory services to private equity clients and business owners in the healthcare, consumer, energy, and business services sectors. She received a Bachelor of Science in economics from the University of Pennsylvania’s Wharton School.